RU93005168A - Индолиновые производные, способ их получения, промежуточные соединения синтеза, использование промежуточных соединений и фармацевтическая композиция - Google Patents

Индолиновые производные, способ их получения, промежуточные соединения синтеза, использование промежуточных соединений и фармацевтическая композиция

Info

Publication number
RU93005168A
RU93005168A RU93005168/04A RU93005168A RU93005168A RU 93005168 A RU93005168 A RU 93005168A RU 93005168/04 A RU93005168/04 A RU 93005168/04A RU 93005168 A RU93005168 A RU 93005168A RU 93005168 A RU93005168 A RU 93005168A
Authority
RU
Russia
Prior art keywords
compounds
producing
pharmaceutical composition
indoline derivatives
intermediate synthesis
Prior art date
Application number
RU93005168/04A
Other languages
English (en)
Other versions
RU2104268C1 (ru
Inventor
Ваньон Жан
Плузан Клод
Серрадей-Легаль Клодин
Низато Дино
Тоннер Бернар
Original Assignee
Елф Санофи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9109908A external-priority patent/FR2679903B1/fr
Application filed by Елф Санофи filed Critical Елф Санофи
Publication of RU93005168A publication Critical patent/RU93005168A/ru
Application granted granted Critical
Publication of RU2104268C1 publication Critical patent/RU2104268C1/ru

Links

Claims (1)

  1. Изобретение относится к новым индолиновым производным, к способу их получения и фармацевтическим композициям на их основе. Эти соединения могут быть использованы при лечении расстройств центральной нервной системы, сердечно-сосудистой и желудочной систем у человека и животных.
RU93005168A 1991-08-02 1992-07-31 Индолиновые производные, способ их получения, промежуточные соединения, фармацевтическая композиция RU2104268C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9109908A FR2679903B1 (fr) 1991-08-02 1991-08-02 Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
FR9109908 1991-08-02
PCT/FR1992/000758 WO1993003013A1 (fr) 1991-08-02 1992-07-31 Derives d'indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant

Publications (2)

Publication Number Publication Date
RU93005168A true RU93005168A (ru) 1996-12-20
RU2104268C1 RU2104268C1 (ru) 1998-02-10

Family

ID=9415909

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93005168A RU2104268C1 (ru) 1991-08-02 1992-07-31 Индолиновые производные, способ их получения, промежуточные соединения, фармацевтическая композиция

Country Status (29)

Country Link
EP (1) EP0526348B1 (ru)
JP (1) JP2633085B2 (ru)
KR (1) KR100241583B1 (ru)
AT (1) ATE163289T1 (ru)
AU (2) AU658664B2 (ru)
BR (1) BR9205336A (ru)
CA (2) CA2206776C (ru)
CZ (1) CZ288173B6 (ru)
DE (1) DE69224450T2 (ru)
DK (1) DK0526348T3 (ru)
ES (1) ES2117038T3 (ru)
FI (2) FI104069B (ru)
FR (1) FR2679903B1 (ru)
HK (1) HK1008741A1 (ru)
HU (2) HUT68927A (ru)
IL (3) IL117592A (ru)
LT (1) LT3064B (ru)
LV (1) LV10091B (ru)
MX (1) MX9204487A (ru)
MY (1) MY110517A (ru)
NO (1) NO180047C (ru)
NZ (1) NZ243795A (ru)
PH (1) PH30661A (ru)
RU (1) RU2104268C1 (ru)
SG (1) SG47501A1 (ru)
SK (1) SK283463B6 (ru)
UA (1) UA27238C2 (ru)
WO (1) WO1993003013A1 (ru)
ZA (1) ZA925781B (ru)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665441B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.
FR2708608B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
FR2756736B1 (fr) * 1996-12-05 1999-03-05 Sanofi Sa Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
US6939855B2 (en) 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
PL338457A1 (en) * 1997-07-31 2000-11-06 Elan Pharm Inc Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4
US6489300B1 (en) 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
US6423688B1 (en) 1997-07-31 2002-07-23 Athena Neurosciences, Inc. Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6583139B1 (en) 1997-07-31 2003-06-24 Eugene D. Thorsett Compounds which inhibit leukocyte adhesion mediated by VLA-4
IL133641A0 (en) * 1997-07-31 2001-04-30 Elan Pharm Inc Compounds which inhibit leukocyte adhesion mediated by vla-4
US6291453B1 (en) 1997-07-31 2001-09-18 Athena Neurosciences, Inc. 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US7030114B1 (en) 1997-07-31 2006-04-18 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
KR20010022406A (ko) * 1997-07-31 2001-03-15 진 엠. 듀발 Ｖｌａ-4에 의해 매개되는 백혈구 유착을 억제하는디펩타이드 및 관련 화합물
US6362341B1 (en) 1997-07-31 2002-03-26 Athena Neurosciences, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
US6492421B1 (en) 1997-07-31 2002-12-10 Athena Neurosciences, Inc. Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
FR2775598A1 (fr) * 1998-03-06 1999-09-10 Sanofi Sa Compositions pharmaceutiques contenant en association un antagoniste selectif des recepteurs v1a de l'arginine-vasopressine et un antagoniste selectif des recepteur v2 de l'arginine-vasopressine
FR2778103A1 (fr) * 1998-04-29 1999-11-05 Sanofi Sa Compositions pharmaceutiques contenant en association un antagoniste v1a de l'arginine-vasopressine et un antagoniste des recepteurs at1 de l'angiotensine ii
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
JP2002535316A (ja) 1999-01-22 2002-10-22 エラン ファーマシューティカルズ，インコーポレイテッド Ｖｌａ−４により媒介される白血球接着を阻害する縮合環へテロアリールおよび複素環式化合物
CA2359115C (en) 1999-01-22 2011-06-21 Elan Pharmaceuticals, Inc. Acyl derivatives which treat vla-4 related disorders
WO2000043415A1 (en) * 1999-01-25 2000-07-27 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by vla-4
US6436904B1 (en) 1999-01-25 2002-08-20 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6407066B1 (en) 1999-01-26 2002-06-18 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
FR2792834A1 (fr) * 1999-04-29 2000-11-03 Sanofi Sa Utilisation du sr 49059, de ses solvats et/ou hydrates pharmaceutiquement acceptables, pour la preparation de medicaments utiles dans le traitement ou la prevention du phenomene de raynaud
FR2805536B1 (fr) * 2000-02-25 2002-08-23 Sanofi Synthelabo Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
AU2002214019B2 (en) 2000-10-17 2007-01-25 Merck Serono Sa Pharmaceutically active sulfanilide derivatives
US7056910B2 (en) 2000-11-28 2006-06-06 Astellas Pharma Inc. 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof
JP4044740B2 (ja) * 2001-05-31 2008-02-06 信越化学工業株式会社 レジスト材料及びパターン形成方法
US7468385B2 (en) 2001-12-20 2008-12-23 Laboratoires Serono Sa Triazoles as oxytocin antagonists
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
WO2003099773A1 (en) 2002-05-24 2003-12-04 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
CA2498091C (en) * 2002-10-11 2011-03-22 Actelion Pharmaceuticals Ltd. Sulfonylamino-acetic acid derivatives
US7420055B2 (en) 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
US7227035B2 (en) 2002-11-18 2007-06-05 Chemocentryx Bis-aryl sulfonamides
KR100866456B1 (ko) 2002-11-18 2008-10-31 케모센트릭스 아릴 술폰아마이드
US7741519B2 (en) 2007-04-23 2010-06-22 Chemocentryx, Inc. Bis-aryl sulfonamides
EP1940827B1 (en) 2005-09-29 2011-03-16 Elan Pharmaceuticals Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
NZ567270A (en) 2005-09-29 2011-06-30 Elan Pharm Inc Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
NZ570679A (en) 2006-02-27 2011-01-28 Elan Pharm Inc Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated By VLA-4
SG10201401836RA (en) 2009-04-27 2014-10-30 Elan Pharm Inc Pyridinone antagonists of alpha-4 integrins
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838167A (en) * 1972-08-01 1974-09-24 Lilly Co Eli Process for preparing indoles
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
DE3705934A1 (de) * 1987-02-25 1988-09-08 Nattermann A & Cie Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
FR2665441B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.

Similar Documents

Publication Publication Date Title
RU93005168A (ru) Индолиновые производные, способ их получения, промежуточные соединения синтеза, использование промежуточных соединений и фармацевтическая композиция
RU93005350A (ru) Новые замещенные фенилимидазолидины, способ их получения, их применение в качестве медикаментов и включающие их фармацевтические соединения
PT100514A (pt) 3-aminoquinuclidinas substituidas e composicoes farmaceuticas que qs contem
RU93058531A (ru) Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ лечения
IL93508A0 (en) Novel benzimidazole and azabenimidazole derivatives,their methods of preparation,synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers
RU94040864A (ru) Конденсированные индольные производные, их получение, фармацевтическая композиция
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
NO174239C (no) Fremgangsmåte for fremstilling av et oralt, farmasöytisk preparat
RU93004793A (ru) Производные хиназолина, способ их получения, фармацевтическая композиция на их основе
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
IL115073A (en) Use of 5-substituted pyridine-and hexahydroquinoline-3-carboxylic acid derivatives for the preparation of pharmaceutical compositions for the treatment of disorders of the central nervous system some such novel compounds their preparation and pharmaceutical compositions containing them
DE515995T1 (de) N-(5-thioxo-l-propyl)-l-cystein und derivate, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
DE68905171T2 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
ATE112276T1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
IL83586A0 (en) Substituted hexahydroarylquinolizines and pharmaceutical compositions containing them
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
DE69722816D1 (de) Neue derivate von benzoylalkyl-1,2,3,6-tetrahydropyridinen
RU92004492A (ru) Сульфонимидамиды, способы их получения, фармацевтическая композиция
RU93045455A (ru) Производные пиперидина, способ их получения и фармацевтическая композиция на их основе
RU92004330A (ru) Производные тиадиазинона, способ их получения, фармацевтическая композиция и способ ее получения, применение соединений для борьбы с заболеваниями
MA22731A1 (fr) Procede de preparation de compositions pharmaceutiques
RU93057886A (ru) Производные 2-тиенилимидазо (2,1-b) бензтиазол-3-уксусной кислоты, способ их получения и фармацевтическая композиция на их основе
RU93046413A (ru) Производные пиперидина, способ их получения и фармацевтическая композиция на их основе
RU93004901A (ru) Хинуклидиновые производные, способ их получения, фармацевтическая композиция, способ лечения